3.63
2.94%
-0.11
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cardiff Oncology Inc Borsa (CRDF) Ultime notizie
Cardiff Oncology to Present at Upcoming Investor Conferences in May - GlobeNewswire
GlobeNewswire
Cardiff Oncology to Present at Upcoming Investor Conferences in May
GlobeNewswire Inc.
Cardiff Oncology, Inc. Forecasted to Post FY2024 Earnings of ($0.98) Per Share (NASDAQ:CRDF) - Defense World
Defense World
FY2024 Earnings Forecast for Cardiff Oncology, Inc. (NASDAQ:CRDF) Issued By HC Wainwright - MarketBeat
MarketBeat
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 - PrimePublishers.com
PrimePublishers.com
Cardiff Oncology (CRDF) Loses -29.75% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Singapore News
Yahoo Singapore News
Cardiff Oncology's (CRDF) Buy Rating Reiterated at HC Wainwright - Defense World
Defense World
The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028 - InvestorPlace
InvestorPlace
Cardiff Oncology (NASDAQ:CRDF) Rating Reiterated by HC Wainwright - MarketBeat
MarketBeat
Take the Zacks Approach to Beat the Markets: Navios Maritime, Coinbase Global, Virtu Financial in Focus
Zacks Investment Research
Cardiff Oncology (NASDAQ:CRDF) Rating Reiterated by HC Wainwright - MarketBeat
MarketBeat
Head to Head Comparison: Cardiff Oncology (NASDAQ:CRDF) and Finch Therapeutics Group (NASDAQ:FNCH) - Defense World
Defense World
Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Yahoo Finance
Earnings call: Cardiff Oncology reports on CRDF-004 trial progress - Investing.com India
Investing.com India
Cardiff Oncology, Inc. (NASDAQ:CRDF) Q1 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Cardiff Oncology earnings beat by $0.03, revenue topped estimates - Investing.com South Africa
Investing.com South Africa
Cardiff Oncology: Q1 Earnings Snapshot - Houston Chronicle
Houston Chronicle
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
GlobeNewswire Inc.
Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update - GlobeNewswire
GlobeNewswire
Net Present Value Model: Cardiff Oncology Inc's Onvansertib Fumarate - GlobalData
GlobalData
Understanding the Risks of Investing in Cardiff Oncology Inc (CRDF) – Knox Daily - Knox Daily
Knox Daily
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
GlobeNewswire Inc.
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS ... - GlobeNewswire
GlobeNewswire
Cardiff Oncology (CRDF) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks Investment Research
Cardiff Oncology (CRDF) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Yahoo Finance
Thinking about buying stock in Cardiff Oncology, BIOLASE, Akebia Therapeutics, Astera Labs, or Atossa Therapeutics? - PR Newswire
PR Newswire
Cardiff (CRDF) Stock Rallies 194% in a Month: Here's Why
Zacks Investment Research
Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5 - InvestorPlace
InvestorPlace
Here's Why Momentum in Cardiff Oncology (CRDF) Should Keep going
Zacks Investment Research
Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last?
Zacks Investment Research
Thinking about buying stock in SoundHound AI, Kinross Gold, Nu Holdings, Cardiff Oncology, or Turtle Beach? - Marketscreener.com
Marketscreener.com
Should You Buy Cardiff Oncology Inc (CRDF) Stock After it Is Up 46.27% in a Week? - InvestorsObserver
InvestorsObserver
Will Cardiff Oncology Inc (CRDF) Beat the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver
InvestorsObserver
Cardiff Oncology: Why The Bulls Are Winning Right Now (Rating Upgrade) (NASDAQ:CRDF) - Seeking Alpha
Seeking Alpha
Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024
GlobeNewswire Inc.
What Makes Cardiff Oncology (CRDF) a Strong Momentum Stock: Buy Now?
Zacks Investment Research
Cardiff Oncology (NASDAQ:CRDF) Price Target Raised to $14.00 - MarketBeat
MarketBeat
Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher
Benzinga
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Finding Long Term Penny Stocks Investments? 3 Tips
PennyStocks
Penny Stocks & Cryptocurrency, How Are They Related?
PennyStocks
We're Not Very Worried About Cardiff Oncology's (NASDAQ:CRDF) Cash Burn Rate - Simply Wall St
Simply Wall St
Crude Oil Rises Over 2%; Fisker Shares Plummet
Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Nasdaq Surges 100 Points; ISM Manufacturing PMI Falls In February
Benzinga
Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Benzinga
Cardiff Oncology Inc (CRDF) Reports Q4 and Full Year 2023 Financial Results - Yahoo Finance
Yahoo Finance
Capitalizzazione:
|
Volume (24 ore):